Yüklüyor......
Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
Aim: Kidney impairment is observed in patients with COVID-19. The effect of anti-COVID-19 agent remdesivir on kidneys is currently unknown. We aimed to determine the effect of remdesivir on renal fibrosis and its downstream mechanisms. Methods: Remdesivir and its active nucleoside metabolite GS-4415...
Kaydedildi:
| Yayımlandı: | Front Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8284048/ https://ncbi.nlm.nih.gov/pubmed/34276356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.626510 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|